These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

992 related articles for article (PubMed ID: 33210980)

  • 1. Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: A systematic review and meta-analysis.
    Singh AK; Jena A; Kumar-M P; Sharma V; Sebastian S
    United European Gastroenterol J; 2021 Mar; 9(2):159-176. PubMed ID: 33210980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of adverse outcomes in inflammatory bowel disease patients infected with SARS-CoV-2: a systematic review and meta-analysis.
    Chen L; Hu K; Cheng C; Hu Q; Zhang L; An T; Guo Y; Chen S; Duan G
    Int J Colorectal Dis; 2022 Nov; 37(11):2277-2289. PubMed ID: 36271206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 susceptibility and clinical outcomes in inflammatory bowel disease: An updated systematic review and meta-analysis.
    Lee MH; Li HJ; Wasuwanich P; Kim SE; Kim JY; Jeong GH; Park S; Yang JW; Kim MS; Yon DK; Lee SW; Koyanagi A; Jacob L; Kim EY; Cheon JH; Shin JI; Smith L
    Rev Med Virol; 2023 Mar; 33(2):e2414. PubMed ID: 36504172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe COVID-19 in inflammatory bowel disease patients in a population-based setting.
    Creemers RH; Rezazadeh Ardabili A; Jonkers DM; Leers MPG; Romberg-Camps MJ; Pierik MJ; van Bodegraven AA
    PLoS One; 2021; 16(10):e0258271. PubMed ID: 34610041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study.
    Bezzio C; Armuzzi A; Furfaro F; Ardizzone S; Milla M; Carparelli S; Orlando A; Caprioli FA; Castiglione F; Viganò C; Ribaldone DG; Zingone F; Monterubbianesi R; Imperatore N; Festa S; Daperno M; Scucchi L; Ferronato A; Pastorelli L; Balestrieri P; Ricci C; Cappello M; Felice C; Fiorino G; Saibeni S;
    Aliment Pharmacol Ther; 2021 Dec; 54(11-12):1432-1441. PubMed ID: 34694009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Review on Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: It Is Time to Take Stock.
    D'Amico F; Danese S; Peyrin-Biroulet L
    Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2689-2700. PubMed ID: 32777550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19.
    Macaluso FS; Giuliano A; Fries W; Viola A; Abbruzzese A; Cappello M; Giuffrida E; Carrozza L; Privitera AC; Magnano A; Ferracane C; Scalisi G; Minissale MG; Giangreco E; Garufi S; Bertolami C; Cucinotta U; Graziano F; Casà A; Renna S; Teresi G; Rizzuto G; Mannino M; Maida M; Orlando A
    Inflamm Bowel Dis; 2023 Feb; 29(2):217-221. PubMed ID: 35385102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in Coronavirus disease - 19 vaccination related side effects in patients with ulcerative colitis and Crohn's disease in Japan.
    Miyazaki H; Watanabe D; Ito Y; Ikeda S; Okamoto N; Tokunaga E; Ku Y; Ooi M; Hoshi N; Kodama Y
    Indian J Gastroenterol; 2023 Oct; 42(5):701-707. PubMed ID: 37505394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Outcomes of Covid-19 in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study.
    Derikx LAAP; Lantinga MA; de Jong DJ; van Dop WA; Creemers RH; Römkens TEH; Jansen JM; Mahmmod N; West RL; Tan ACITL; Bodelier AGL; Gorter MHP; Boekema PJ; Halet ERC; Horjus CS; van Dijk MA; Hirdes MMC; Epping Stippel LSM; Jharap B; Lutgens MWMD; Russel MG; Gilissen LPL; Nauta S; van Bodegraven AA; Hoentjen F
    J Crohns Colitis; 2021 Apr; 15(4):529-539. PubMed ID: 33079178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.
    Ng SC; Shi HY; Hamidi N; Underwood FE; Tang W; Benchimol EI; Panaccione R; Ghosh S; Wu JCY; Chan FKL; Sung JJY; Kaplan GG
    Lancet; 2017 Dec; 390(10114):2769-2778. PubMed ID: 29050646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 and Outcomes in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.
    Tripathi K; Godoy Brewer G; Thu Nguyen M; Singh Y; Saleh Ismail M; Sauk JS; Parian AM; Limketkai BN
    Inflamm Bowel Dis; 2022 Aug; 28(8):1265-1279. PubMed ID: 34718595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory bowel disease and risk of severe COVID-19: A nationwide population-based cohort study in Sweden.
    Ludvigsson JF; Axelrad J; Halfvarson J; Khalili H; Larsson E; Lochhead P; Roelstraete B; Simon TG; Söderling J; Olén O
    United European Gastroenterol J; 2021 Mar; 9(2):177-192. PubMed ID: 33704918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 outcomes in patients with inflammatory bowel diseases in Latin America: Results from SECURE-IBD registry.
    Queiroz NSF; Martins CA; Quaresma AB; Hino AAF; Steinwurz F; Ungaro RC; Kotze PG
    J Gastroenterol Hepatol; 2021 Nov; 36(11):3033-3040. PubMed ID: 34151470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysis.
    James D; Jena A; Bharath PN; Choudhury A; Singh AK; Sebastian S; Sharma V
    Dig Liver Dis; 2022 Jun; 54(6):713-721. PubMed ID: 35382972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for SARS-CoV-2 infection and course of COVID-19 disease in patients with IBD in the Veterans Affair Healthcare System.
    Khan N; Mahmud N; Trivedi C; Reinisch W; Lewis JD
    Gut; 2021 Sep; 70(9):1657-1664. PubMed ID: 33753416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory bowel disease and COVID-19 outcomes: a meta-analysis.
    Abdulla M; Mohammed N; AlQamish J; Mosli M
    Sci Rep; 2022 Dec; 12(1):21333. PubMed ID: 36494448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic.
    Lin S; Lau LH; Chanchlani N; Kennedy NA; Ng SC
    Gut; 2022 Jul; 71(7):1426-1439. PubMed ID: 35477864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low frequency of COVID-19 in inflammatory bowel diseases.
    Marafini I; Salvatori S; Sena G; Calabrese E; Biancone L; Monteleone G
    Dig Liver Dis; 2020 Nov; 52(11):1234-1235. PubMed ID: 32601036
    [No Abstract]   [Full Text] [Related]  

  • 20. Is Having Inflammatory Bowel Disease a Risk Factor for Severe Acute Respiratory Syndrome Coronavirus 2?
    Çavuş B; Akyüz F; Örmeci Çifçibaşı A; Özgür İ; Erel C; Yakut A; İmanov Z; Şenkal İV; Medetalibeyoğlu A; Köse M; Keskin M; Demir K; Beşışık F; Kaymakoğlu S
    Turk J Gastroenterol; 2022 Mar; 33(3):196-204. PubMed ID: 35410854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.